Correlation Between Corvus Pharmaceuticals and Erasca

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Erasca at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Erasca into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Erasca Inc, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Erasca and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Erasca. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Erasca.

Diversification Opportunities for Corvus Pharmaceuticals and Erasca

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Corvus and Erasca is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Erasca Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erasca Inc and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Erasca. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erasca Inc has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Erasca go up and down completely randomly.

Pair Corralation between Corvus Pharmaceuticals and Erasca

Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 1.9 times less return on investment than Erasca. But when comparing it to its historical volatility, Corvus Pharmaceuticals is 1.22 times less risky than Erasca. It trades about 0.16 of its potential returns per unit of risk. Erasca Inc is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  143.00  in Erasca Inc on September 3, 2025 and sell it today you would earn a total of  146.00  from holding Erasca Inc or generate 102.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Corvus Pharmaceuticals  vs.  Erasca Inc

 Performance 
       Timeline  
Corvus Pharmaceuticals 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Erasca Inc 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Erasca Inc are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Erasca unveiled solid returns over the last few months and may actually be approaching a breakup point.

Corvus Pharmaceuticals and Erasca Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Corvus Pharmaceuticals and Erasca

The main advantage of trading using opposite Corvus Pharmaceuticals and Erasca positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Erasca can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erasca will offset losses from the drop in Erasca's long position.
The idea behind Corvus Pharmaceuticals and Erasca Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance